Peer-influenced content. Sources you trust. No registration required. This is HCN.

Researcher Blows the Whistle on Data Integrity Issues in Pfizer’s Vaccine Trial

BMJ’s investigation findings raise questions about data integrity and regulatory oversight concerning Pfizer’s vaccine trial. A regional director told the BMJ that Pfizer falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in the pivotal phase III trial.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form